16.8 C
New York
Friday, June 25, 2021
- Advertisement -

TAG

COVID19

Pfizer [NYSE: PFE] Announces Third Quarter 2021 Dividend

Pfizer Inc. disclosed that its board of directors announced a 39-cent third-quarter 2021 dividend on the common stock of the firm, outstanding September...

Trxade [NASDAQ: MEDS] Launch Health Passport App

Trxade Group, Inc. disclosed Thursday that it has rolled out a Health Passport app. The app is currently available, and users can download...

Takeda [NYSE: TAK] Confirms Approval of Moderna’s COVID-19 Vaccine in Japan

Takeda Pharmaceutical Company Limited disclosed Friday that the Ministry of Health, Labour and Welfare (MHLW) has provided the special authorization under article 14-3...

Amazon [NASDAQ: AMZN] Decides to Offer In-Garage Grocery Delivery to Prime Members

Amazon.com, Inc. revealed that it has decided to grow In-Garage Grocery Delivery everywhere. The grocery delivery from Amazon is accessible to and offering...

Emergent BioSolutions [NYSE: EBS] Reaffirms 2021 Financial Guidance

Emergent BioSolutions Inc. has confirmed the business guidance for 2021. US-based drug manufacturer asserted that it would proceed with its manufacturing pacts linked...

Johnson & Johnson [NYSE: JNJ] Inks Supply Deal of up to $400M Doses of COVID-19

Johnson & Johnson disclosed that one of the Janssen Pharmaceutical Firms of Janssen Pharmaceutica NV inked a deal with the AVATT. The supply...

QIAGEN [NYSE: QGEN] Gets FDA EUA for NeuMoDx

QIAGEN N.V. revealed that it has obtained EUA from FDA for NeuMoDx Flu A-B/RSV/SARS-CoV-2. NeuMoDx will assist health-care experts in rapidly recognize and...

Regeneron’s [NASDAQ: REGN] COVID19 Antibody Lessens Hospitalization Risk

Regeneron Pharmaceuticals, Inc. disclosed that its COVID-19 antibody has shown positive results in the largest trial. The firm has revealed that its investigational...

Boeing [NYSE: BA] Announces $5.28 Billion Revolving Credit Agreement

The Boeing Company disclosed that it has inked a two-year revolving credit agreement. The decision has been taken but the firm after the...

GenMark [NASDAQ: GNMK] to be Acquired by Roche

Roche has disclosed that it has decided to purchase GenMark Diagnostics, Inc. for a total of $1.8 billion. Roche is planning to commence...

Latest news

- Advertisement -